Adenocarcinoma of the Pancreas Recruiting Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02394535Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerTreatment
NCT03703089Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal CytologyTreatment
NCT03703063Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerTreatment
NCT02495896Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsTreatment
NCT03307148Stromal TARgeting for PAncreatic Cancer (STAR_PAC)Treatment